Neonatal Diagnostics Company InfanDx AG Completes Two-Year :

Clinical data curation and evaluation ongoingFollow-up rate of 77% fully meets expectations (70-80%) Final HIE biomarker panel validation data expected by...

Related Keywords

Germany , United States , Furtwangen , Baden Wüberg , Boston , Massachusetts , Bonn , Nordrhein Westfalen , Turkey , Jordan , Berlin , German , Ludger Wess Ines Regina Buth , Axel Franz , Peter Bartmann , Infandx Hypox , Gunter Weiss , Hans Peter Deigner , Personalized Medicine At Furtwangen University , Contract Research Organization , Head Of The Research Group , University Hospital Of Tuebingen , Matthias Kohl At Furtwangen University , Meeting Of The German Society For Neonatology , Steinbeis Transfer Center , Infandx United States Inc , University Of Bonn , Annual Meeting , German Society , Pediatric Intensive Medicine , Hypoxic Ischemic Encephalopathy , Hypoxe Test , Achim Plum , Research Group , Pediatric Clinical Studies , University Hospital , Personalized Medicine , Furtwangen University , Matthias Kohl , Infandx Hypoxe , Ludger Wess , Ines Regina Buth , Akampion , Eonatal Diagnostics , Eonatal Diagnostik ,